5Yancy C W, Jessup M, Bozkurt B, et al. 2013 ACCF/ AHA guideline for the management of heart failure: a re- port of the American College of Cardiology Foundation/A- merican Heart Association Task Force on Practice Guide- lines [ J ]. J Am Coil Cardiol, 2013,62 (16) : e147-e239.
6Frenneaux M P. Autonomic :Changes in patients with heart failure and in post-myocardial infarction patients [ J ]. Heart, 2004,90( 11 ) : 1248-1255.
7Cohn J N, Levine T B, Olivari M T, et al. Plasma nor- epinephrine as a guide to prognosis in patients with chron- ic congestive heart failure[J]. N Engl J Med, 1984,311 (13) :819-823.
8Nolan J, Flapan A D, Capewell S, et al. Decreased car- diac parasympathetic activity in chronic heart failure and its relation to left ventricular function [ J ]. Br Heart J, 1992,67(6) :482-485.
9Nolan J, Flapan A D, Goodefield N E, et al. Measure- ment of parasympathetic activity from 24-hour ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischemia, and patients with diabetes mellitus [ J ]. Am J Cardiol, 1996,77(2) :154-158.
10Chattipakorn N, Incharoen T, Kanlop N, et al. Heart rate variability in myocardial infarction and heart failure [ J ]. Int J Cardiol, 2007,120 ( 3 ) :289-296.
